Search Results
Sep 01, 2026, 06:45 ET Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance
related to the Scientia Vascular (Scientia) acquisition in the Specialty Therapies division, $5 million of inorganic revenue related to the SPR Therapeutics, Inc. (SPR) acquisition in the Neuromodulation division, and $57 million of favorable currency impact on the remaining net sales. The three months ended
More news about: Medtronic plc
Aug 26, 2026, 20:00 ET Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result
sequences each. All submitted sequences were expressed as full-length IgG by the organizers under uniform conditions, first measured for affinity by SPR, with high-affinity candidates then further validated by single-point and standard KinExA.Affinity alone was not enough. Each antibody also had
More news about: Aureka
Aug 11, 2026, 05:00 ET Global Precision Parts Market to Reach USD 376.96 Billion by 2031 as OEM Demand Moves Toward Higher-Value Components - Arizton
Products Inc.Lampin CorporationZollern GmbHRosenbergerHartford TechnologiesPrecision Resource Inc.SPR GroupSpaleck GroupAce Precision Machining Corp.Lemor Mechanical Industry Ltd.Cox Manufacturing Company Inc.UnimechSFS
More news about: Arizton Advisory & Intelligence
Aug 05, 2026, 09:52 ET Biointron Launches RushData, an Integrated High-Throughput Platform for AI-Driven Antibody Discovery
structured AI/ML-ready data from processing 3,000+ molecules per batch in parallelBinding characterization using BLI and/or SPR, integrated directly with expression and purity dataEarly developability profiling in selected packages, including:Differential
More news about: Biointron
Jul 21, 2026, 11:01 ET TYBR Health Announces $30 Million Series A Financing to Expand Access to the B3 GEL® System
Capital Partners' investment team has a history of successfully partnering with entrepreneurs behind industry-leading companies, including recent exits SPR Therapeutics, eBlu Solutions, as well as OrthoHelix, Cleveland Heartlab, TFX Medical, RevLocal, and Cardinal Commerce.
More news about: TYBR Health
Jul 16, 2026, 09:00 ET Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain
/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of SPR Therapeutics, Inc. (SPR), a privately held medical technology company and recognized leader in short-term, percutaneous peripheral nerve stimulation (PNS) therapies
More news about: Medtronic plc
Jun 03, 2026, 06:45 ET Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years
adjacencies: completed CathWorks acquisition in Coronary and Renal Denervation; announced intention to acquire both Scientia Vascular in Neurovascular and SPR Therapeutics in Neuromodulation (in May); entered into agreements with Merit Medical Systems to offer ViaVerte™ system in Neuromodulation; and an investment
More news about: Medtronic plc
May 27, 2026, 08:00 ET From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
route for assessing biological activity across large compound collections. For more challenging targets, affinity-based approaches such as DEL, ASMS, or SPR can help address early questions around druggability, particularly when protein availability or assay readiness is limited.The discussion also
More news about: Viva Biotech
May 27, 2026, 08:00 ET From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
route for assessing biological activity across large compound collections. For more challenging targets, affinity-based approaches such as DEL, ASMS, or SPR can help address early questions around druggability, particularly when protein availability or assay readiness is limited.The discussion also
More news about: Viva Biotech
May 22, 2026, 06:02 ET 14 Press Releases You Need to See This Week
Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic painThe acquisition will enhance Medtronic's Neuromodulation
More news about: PR Newswire
May 20, 2026, 09:15 ET Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain
20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global healthcare technology leader, today announced its intent to acquire SPR Therapeutics, Inc. (SPR), a privately held medical technology company and a recognized leader in temporary, percutaneous peripheral nerve stimulation (PNS) therapies
More news about: Medtronic plc
May 07, 2026, 09:56 ET Where Science Meets Impact: A Landmark Year for the Pediatric Research Community at the PAS 2026 Meeting
Society for Pediatric Research (SPR).For more information, visit
More news about: Pediatric Academic Societies Meeting
May 06, 2026, 12:10 ET TCL CSOT Showcases APEX Pixel Full-Path Innovation Across Advanced Displays at SID Display Week 2026
Pixel technology, which delivers a powerful trifecta of benefits:Higher Clarity: Achieves sharpness comparable to WQHD SPR. By increasing the sub-pixel quantity by approximately 1.8%, it renders images that are more accurate, clear, and finely detailed.Smarter
More news about: TCL CSOT
May 04, 2026, 09:44 ET Converge Bio uses ConvergeAB to improve popular cancer treatment with a single prompt
the platform generated 100,000 antibody candidates and identified a design that consistently outperformed them in experimental validation, including SPR (surface plasmon resonance) and kinetic characterization for precise KD determination, achieving an average binding affinity 2.1x stronger than cetuximab
More news about: Converge Bio
Apr 07, 2026, 09:00 ET In-Store Marketplace Launches New Framework for In-Store Media Success
introduces a new measurement framework called the Shopper Purchase Rate (SPR). SPR evaluates in-store media performance through three core components: dollars spent, units sold, and shopper behavior across defined segments.SPR is designed to work within existing retail methodologies, including matched-market
More news about: In-Store Marketplace
Mar 26, 2026, 06:10 ET Inadev Appoints Paul Matteucci as a Federal Partner to Lead Regulatory Agencies Portfolio and Accelerate Growth
agencies such as the National Passenger Railroad Administration (Amtrak), National Nuclear Security Administration (NNSA), Strategic Petroleum Reserve (SPR), National Aeronautics and Space Administration (NASA), and General Services Administration (GSA), National Center for Missing and Exploited Children
More news about: Inadev
Mar 24, 2026, 08:30 ET Accelerating GLP-1 Peptides to Market Through Integrated Formulation & Analytical Development, Upcoming Webinar Hosted by Xtalks
GLP-1 peptide quality and lifecycle management. Techniques, including LC-MS, SEC-MALS, surface plasmon resonance (SPR), peptide mapping, cell-based bioassays and stability-indicating methods, will be discussed from both scientific and regulatory perspectives. The session
More news about: Xtalks
Mar 11, 2026, 17:46 ET Global Minimally Invasive Surgical Devices Market to Witness Upsurge in Growth at a CAGR of ~7% by 2034 | DelveInsight
https://www.delveinsight.com/sample-request/minimally-invasive-surgical-mis-devices-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr
More news about: DelveInsight Business Research, LLP
Mar 11, 2026, 17:31 ET Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancements in Psychiatric Therapies | DelveInsight
https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr
More news about: DelveInsight Business Research, LLP
Mar 09, 2026, 17:46 ET Global Telehealth Market is Projected to Cross the USD 2 Trillion Mark by 2034, Driven by Digital Healthcare Transformation | DelveInsight
https://www.delveinsight.com/sample-request/telehealth-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr
More news about: DelveInsight Business Research, LLP
Mar 09, 2026, 17:31 ET Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising Incidence and Advancements in Targeted Therapies | DelveInsight
https://www.delveinsight.com/sample-request/neuroendocrine-carcinoma-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr
More news about: DelveInsight Business Research, LLP
Mar 09, 2026, 12:57 ET Rapidan Energy Group Announces Gulf War III Is by Far the Largest Oil Disruption in History and Has Zeroed Out Spare Capacity
absent. IEA members will come under intense pressure to release strategic stocks – the only remaining supply response option. But Strategic Petroleum Reserve (SPR) releases are finite and insufficient to fully offset the Hormuz loss. Demand destruction and fuel switching will serve as the primary
More news about: Rapidan Energy Group
Mar 05, 2026, 17:31 ET Global Companion Diagnostics Market to Register Immense Growth at a CAGR of ~12% by 2032 | DelveInsight
https://www.delveinsight.com/sample-request/companion-diagnostics-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr
More news about: DelveInsight Business Research, LLP
Mar 05, 2026, 17:31 ET Chronic Rhinosinusitis with Nasal Polyps Market Shows Strong Upward Momentum During the Forecast Period (2026-2036) as Demand for Advanced Therapies Rises | DelveInsight
https://www.delveinsight.com/sample-request/chronic-rhinosinusitis-with-nasal-polyps-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr
More news about: DelveInsight Business Research, LLP
Mar 04, 2026, 18:01 ET Global Nanomedicine Market is Projected to Cross the USD 550 Billion Mark by 2034 as Advanced Drug Delivery Technologies Accelerate Adoption | DelveInsight
@https://www.delveinsight.com/sample-request/nanomedicine-market?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr
More news about: DelveInsight Business Research, LLP